Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.
Abstract: Conventional microarray-based biosensors can only detect a limited number of organisms, and adding sensor capabilities requires re-engineering of reagents and devices to detect the presence ...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...
Regional Association of Methylation variability with the Exposome and geNome (RAMEN) is an R package whose goal is to identify Variable Methylated Regions (VMRs) in microarray DNA methylation data.
Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...
Around 2% of the genomes of modern Eurasians contains Neanderthal DNA. Here's how it affects our health. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...
Abstract: Objective: Predicting the ability of a breast cancer patient to survive was a difficult research problem for many scholars. Since the early dates of the relevant research, significant ...
Valerie is a seasoned writer and editor who has spent her career creating content in the parenting and women's wellness spaces. Before joining Forbes Health, Valerie was the trending news editor at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback